secwatch / observer
8-K filed November 17, 2026, 7:14 AM ET ticker SLS CIK 0001390478
other material confidence high sentiment positive materiality 0.90

SELLAS GPS hits Phase 3 REGAL primary endpoint: median OS 24.0 vs 14.7 months, HR 0.59 (p=0.035)

SELLAS Life Sciences Group, Inc.

Featured in Daily 8-K Digest
Selected #7 for 2026-11-17. Read digest

SELLAS Life Sciences Group, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-26-128825
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.